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Smoking is the primary and most preventable cause of morbidity and mortality in the 
United States, with smoking rates being particularly high among Veterans who 
experience high rates of mental health and substance use disorders. This study 
investigates the prevalence of smoking among depressed patients in Veterans Affairs 
primary care. Correlates of smoking status were examined in order to improve 
understanding of the relations among smoking status, psychosocial characteristics, 
physical and mental health problems, suicide risk, mental health stigma and substance 
misuse, and to find predictive factors of smoking abstinence and cessation over time.  
Study findings have potential to inform development and/or implementation of targeted 
smoking cessation interventions for depressed Veterans presenting in VA primary care.  
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Cigarette smoking is the leading preventable cause of morbidity and mortality in the US 
(Centers for Disease Control [CDC], 2004).  It evidences a causal relationship with eleven types 
of cancer, increases risk for cardiovascular and respiratory diseases, and raises risk for adverse 
reproductive and early childhood effects (US Department of Health and Human Services 
[USDHHS], 2001; CDC, 2004; CDC, 2008).  About half of all smokers in the United States who 
fail to quit will die of a smoking related illness (Morbidity and Mortality Weekly Report 
[MMWR], 2007), and estimates suggest that cigarette smoking accounts for roughly 443,000 
deaths annually (CDC, 2008). Approximately 200,000 of these deaths are accounted for by 
persons with mental illness and substance abuse disorders (Mauer, 2006). Indeed, tobacco use is 
the most significant contributor to premature mortality among people with chronic mental 
illness, who tend to die an average of 25 years earlier than the general population (Schroeder & 
Morris, 2010). These statistics highlight the importance for physicians to advise all smokers--
including those with mental illness--to quit, and in fact, the Agency for Healthcare Research and 
Quality (AHRQ) Clinical Practice Guideline for Treating Tobacco Use and Dependence 
recommends that all tobacco users should be provided with screening and treatment at every 
healthcare visit (Fiore, Bailey, & Cohen, 2000; Fiore, Jaén, Baker, Bailey, Benowitz, Curry, et 
al., 2009). 
Understanding the links between smoking and mental health has potential to inform 
development and/or implementation of treatment aimed at smoking cessation for patients with 
mental health concerns. Some negative mental health conditions associated with smoking—
including mood disorders, anxiety disorders, personality disorders, and substance use 
disorders—appear to predict persistent nicotine dependence among adults in the United States 
(Goodwin, Pagura, Siwak, Leshow, & Sareen, 2011). Indeed, Ong, Zhou, & Sung (2011) found 
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that without smoking cessation counseling, the predicted probabilities of quitting smoking in 
primary care were lower for patients with alcohol, drug, or mental disorders (6.0%) than for 
smokers without these disorders (10.5%). In addition to the obvious health demoting effects of 
smoking, Zevin and Benowitz (1999) noted that smoking increases the metabolism of a variety 
of psychiatric medications, which effectively decreases therapeutic blood levels. 
Whereas causal links regarding associations between smoking and mental health are not 
fully understood, research suggests that multiple physiological and psychological factors 
contribute to the elevated rates of smoking among individuals with mental health and substance 
use disorders (Dursun & Kutcher, 1999; Kendler, Neale, MacLean, Heath, Eaves, & Kessler, 
1993; Ziedonis, Kosten, Glazer, & Frances, 1994). Indeed, the relationship between smoking and 
mental illness has been well documented in the US general population (American Psychiatric 
Association, 1994), with population based studies showing smoking rates among individuals 
with mental disorders to be  nearly twice those of the general population (41% versus 23%) 
(Lasser et al., 2000, Rohde et al., 2003).  
Smoking and Depression 
 Many studies have established associations between depression and cigarette smoking in 
the general population (Kendler, Neale, MacLean, Health, Eaves & Kessler, 1993; Degenhardt, 
2001) with smokers being more likely than nonsmokers to report symptoms of depression 
(Kinnunen, Haukkala, Korhonen, Quiles, Sprio & Garvey, 2006). Research has also shown that 
compared to non-depressed smokers, depressed smokers are less likely to stop smoking and more 
likely to experience smoking relapse (Kinnunen, Doherty, Militello, & Garvey, 1996; Niaura, 
Britt, Shadel, Goldstein, Abrams, & Brown, 2001).  
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Despite the extensive literature on the association between depression and smoking in the 
general US population, researchers have only begun to understand the causal associations, 
suggesting contributing factors such as psychological, social, and genetic (Ziedonis, Hitsman, 
Beckham, Zvolensky, Adler, Audrain-McGovern et al., 2008). One explanation of the 
relationship between depression and tobacco use posited by researchers is the use of smoking as 
a self-regulating mechanism to decrease negative affect, or acute emotional distress associated 
with mental illness (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004). However, little empirical 
evidence has been found to support this explanation of  the co-occurrence of smoking and 
depression (Kassel, Stroud, & Paronis, 2003; Johnson & Breslau, 2006). 
Other proposed explanations supported in the literature include bidirectional causality, 
suggesting that smoking influences depression and depression influences smoking (Breslau, 
Peterson, Schultz, Chilcoat, & Andreski, 1998; Brown, Lewinsohn, Seeley, & Wagner 1996; 
Windle & Windle, 2001), and unidirectional causality, proposing that smoking causes depression 
(Choi, Patten, Gillin, Kaplan, & Pierce, 1997; Klungsoyr, Nygard, Sorensen, & Sandanger, 2006; 
Steuber & Danner, 2006). Evidently, further research is needed to clarify the relationship 
between smoking and depression. Regardless of what the causal relationship may be, it is still 
important to recognize smoking and depression comorbidity and the fact that the two often go 
together.  
Smoking and Mental Illness Among Veterans 
Considering the negative public health burden of smoking, US military Veterans 
represent a unique group of persons, as they present in primary care settings with both higher 
smoking prevalence (27% versus 21%) and with higher prevalence of some mental health 
disorders (50% versus 25%) than those of the adult civilian population (Brown, 2009; Office of 
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Public Health and Environmental Hazards, Department of Veterans Affairs, 2010; Sansone & 
Sansone, 2010; Ziedonis, Williams, Steinberg, Smelson, Sussnr, Foulds, et al., 2005). While 
findings differ based on the VA population assessed, settings, and other factors (Brancu, Straits-
Troster & Kudler, 2011), depression  and PTSD represent the most common mental health 
diagnoses among military personnel and Veterans (20% and 27% respectively) (Brancu, Straits-
Troster & Kudler, 2011; Hankin, Spiro, Miller & Kazis, 1999).  
Although the mechanisms affecting smoking among individuals with PTSD remain 
unclear (Cook, Jakupcak, Roshenheck, Fontana & McFall, 2009), multiple studies have 
documented a link between PTSD and smoking among Veterans (Fu, McFall, Saxon, Beckham, 
Carmody, Baker, & Joseph, 2007). More than half of treatment-seeking Veterans with PTSD 
report smoking (Beckham, Crawford, Feldman, Kirby, Hertzberg, Davidson, et al., 1997). In 
light of findings linking smoking and PTSD, McFall et al. (2005) designed a multisite 
randomized controlled effectiveness trial to test an integrated smoking cessation treatment for 
Veterans with PTSD. In this study, McFall et al. assigned smokers who were in PTSD treatment 
to one of two conditions. The first condition was integrated care, consisiting of smoking 
cessation treatment provided by mental health specialists and integrated within psychiatric care. 
The second condition was a standard care condition wherein smoking cessation treatment was 
provided by a smoking cessation specialist. The authors found that those patients assigned to the 
integrated care condition were five times more likely to quit smoking and to remain abstinent 
during the study window (2, 4, 6, and 9 months) than those PTSD patients assigned to the 
standard care condition (smoking treatment delivered by a smoking cessation specialist).  
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Smoking Relationships with Stigma, Social Support, Alcohol Abuse, and Suicidal Ideation 
Several additional psychosocial and psychiatric factors with potential to contribute to 
smoking are worth examining. Stigma related to mental health conditions and their treatment 
confers stress and subsequent negative affective outcomes (USDHHS, 1999). For example, 
stigma has been found to contribute to loneliness, distress, and discrimination among individuals 
with mental disorders (Hocking, 2003). Mental health stigma also results in a great number of 
negative consequences, such as discrimination in employment and housing  (Byrne, 1997). If 
smoking is employed as a means to regulate the experience of negative affect associated with the 
increased stressors instigated by mental health stigma (Kassel, Stroud, & Paronis, 2003), then it 
is possible that stigma may also contribute indirectly to smoking. Although there appears to be 
limited research on the role of mental health stigma in cigarette smoking and substance abuse in 
general, Lawn, Pols and Barber (2002) found that stigma reduction played a significant role in 
smoking behavior for a sample of community-living psychiatric clients. For these clients, 
smoking provided a sense of freedom and a means to regain autonomy in a world where mental 
health stigma had become part of daily life.  
Tobacco and alcohol use are often co-occurring conditions, with drinkers being more 
likely to smoke cigarettes than nondrinkers, and smokers being more likely to drink than 
nonsmokers (Jackson, Sher, Cooper, & Wood, 2002; Torabi, Bailey, & Jabbari, 1993; Wetzels, 
Kremers, Vitoria & de Vries, 2003). Furthermore, smoking has been associated with relapse to 
drinking (Sandor, 1991; Sobell & Sobell, 1991) and drinking has been associated with smoking 
relapse (Krall, Garvey, & Garcia, 2002).  In addition, the interaction between drinking and 
smoking appears to increase the risk for specific types of cancer and cardiovascular problems 
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(Schlech, Franco, Pintos, Negassa, Kowalski, Oliveira, et al, 1999). Targetting smoking in 
alcohol abuse treatment has not been found to have adverse effects on alcohol abuse treatment 
outcome, and quitting smoking has been found to improve success rates in alcohol abuse 
treatment (Shiffman & Balabanis, 1996). 
Of note, smoking status has demonstrated an association with increased risk of suicidal 
behavior (Hemmingsson & Kriebel, 2003; Iwasaki, Akechi, Uchitomi, & Tsugane, 2005; Moriya 
& Hashimoto, 2005; Riala, Alaraisanen, Taanila, Timonen, & Rasanen, 2007).  Although 
suicidal ideation is a well-known predictor of suicidal behavior and completed suicide (Coombs, 
Miller, Alarcon, Helrihy, Lee, & Morrison, 1992; De Leo, Cerin, Spathonis, & Burgis, 2005), 
there are fewer studies in the literature examining the association between suicidal ideation and 
smoking status. In a study examining suicidal ideation among smokers, former smokers, and 
never smokers, Clarke, Eaton, Petronis, Chatterjee, and Anthony (2010), found current smokers 
to have an increased risk for suicidal ideation, even after controlling for symptoms of depression, 
anxiety, and substance abuse. Understanding the relationship between smoking and suicidal 
ideation can help elucidate mechanisms underlying this association and has potential 
implications for smoking cessation and suicide prevention efforts.  
Finally, a lack of social support confers increased risk of depression  (Hefner & 
Eisenberg, 2009), and some evidence suggests that social support may moderate the relationship 
between depression and smoking cessation (Turner, Mermelstein, Hitsman, Warnaecke, 2008). 
For example, Turner et al. found that depressed women with a recent history of depression who 
reported higher levels of perceived social support were as likely to quit as women without a 
recent history of depression. Indeed, increased social support facilitates smoking cessation 
 
 
7 
efforts, resulting in increased abstinence rates (Cobb, Graham, Bock, Papandonatos, & Abrams, 
2005; Johnson, Alexander, Kapke, McClure, Wiese, Greene, et al., 2009).  
Smoking Cessation Treatment for Individuals with Mental Illness 
Emerging evidence in the treatment domain highlights the importance of mental health 
status considerations in smoking cessation efforts. Multiple studies have shown that smoking 
cessation interventions tailored to the specific needs of individuals with mental illness appear to 
yield more optimal outcomes than non-tailored treatments, including higher cessation rates and 
prolonged abstinence (Hayford et al., 1999; Patten, Martin, Myers, Calfas, & Williams, 1998). In 
a representative study in this area, Schleicher and colleagues (2012) found that, relative to 
controls, depressed smokers in a mood-oriented group treatment for smoking were more likely to 
reduce smoking intensity by 50% and evidenced a greater increase in smoking reduction 
confidence. Whereas these findings hold promise, a recent review and meta-analysis of the 
evidence on the comparative effectiveness of smoking cessation treatment for patients with 
depression, Gierish, Bastian, Calhoun, McDuffie, and Williams (2010) found that very few 
smoking cessation trials included smokers with current depression, and that current or recent 
depressive episodes in patients who smoked actually constituted exclusion criteria for many 
studies (Gierisch, Bastian, Calhoun, McDuffie, & Williams, 2010).   
While the increased effectiveness of smoking cessation interventions tailored for patients 
with mental disorders is worth considering, the high smoking rates among Veterans with mental 
health disorders indicate that smoking cessation services for this population is still in need of 
further improvement. Simple smoking cessation counseling services provided in VA primary 
care settings, beyond obtaining smoking status and offering referrals to smoking cessation 
clinics, could improve cessation rates for smokers with mental disorders. Indeed, a study 
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examining the effects of primary care providers counseling patients on smoking cessation by 
talking to them about quitting or avoiding smoking, found that those smokers with mental health 
and alcohol and substance abuse disorders were as likely to quit smoking as those without these 
disorders (Ong, Zhou, & Sung, 2011).  
Smoking Cessation Implementation Efforts within VA 
Although chronic disease prevention practices have improved dramatically in the VA 
health care system since the 1990s (Sherman, 2008), and AHRQ smoking cessation guidelines 
have been implemented in this system, there is still room for improvement regarding adherence 
to these guidelines.  Studies suggest that only between 50% and 75% of VA smokers are advised 
to quit (Ward et al., 2003; Joseph et al., 2004). Moreover, those smokers who planned to quit 
(approximately 40%) reported receiving help only about half the time, with a small minority 
(21%) receiving medications to aid with smoking cessation (Joseph, Arikian, An, Nugent, Sloan, 
Pieper, et al., 2004).  
In a quality improvement report of a framework for tobacco control, Sherman (2008) 
listed among the lessons learned from Veterans Health Adminstration, the requirement of “a 
more concerted effort than simply having a smoking cessation clinic and waiting for referrals” 
(pg. 1018). Sherman also stressed the need for evidence-based standards of care, measuring 
performance, and systematically identifying and disseminating best practices. Currently, most 
VA settings depend on nursing staff to ask about smoking, but there is no systematic approach to 
offering counseling (Sherman, Yano, Lanto, Simon & Rubenstein, 2005). In addition to 
improving efforts to follow smoking cessation guidelines, physicians in the VA primary care 
system need to recognize the complexities and added benefits of quitting smoking for smokers 
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with mental illness (Schroeder & Morris, 2010) so that they may implement and follow the most 
effective procedures to help this vulnerable population.  
The smoking behavior of depressed Veterans has received considerably less attention 
than that of smokers with PTSD, and to our knowledge, the smoking behavior of depressed 
Veterans in primary care settings in particular has received even less interest. Understanding the 
specific proportions of depressed smokers with co-occurring physical and mental health 
conditions can provide valuable information on the distinctive issues relevant to smoking 
cessation treatment in this setting. In addition, if smoking is used as a self-regulation mechanism, 
then comparing individuals who are depressed and smoke to those who are depressed and do not 
smoke can provide a means of evaluating differences in features of depression as well as other 
psychological or social factors that may influence smoking behavior (Ziedonis, Hitsman, 
Beckham, Zvolensky, Adler, Audrain-McGovern et al., 2008).  
Depression has also been shown to be a risk factor for negative health consequences, 
such as cardiovascular illness and several types of cancer (Knet, Raitasalo, Heliovaara, Lehtinen, 
Pukkala, Teppo, Maatela & Aromaa, 1996; Glassman & Shapiro, 1998; Linkins & Comstock, 
1990).  A greater understanding of the increased morbidity of depressed smokers, including the 
role of co-occurring PTSD, substance use, anxiety disorders, and possible attenuating factors 
such as the role of social support, can help elucidate important issues worth considering in the 
development of effective smoking cessation treatment for this population. Furthermore, Barnett, 
Wong, & Hall (2008) evaluated a smoking cessation program for outpatients with depression and 
deemed it to be cost effective. Indeed, smoking cessation programs have been found to be 
significantly more cost-effective than most medical care interventions (Warner, 1997).  
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It appears that smoking cessation counseling that is easily accessible and does not require 
the smoker to take an additional step to receive smoking cessation services (e.g., go to a separate 
appointment at a smoking cessation clinic) can improve cessation rates for individuals with these 
disorders. Study findings indicate that simply offering referrals to smoking cessation clinics does 
not improve quit rates in a VA primary care, and that having an on-call smoking cessation 
counselor can be an effective approach to improving smoking cessation treatment (Yano et al., 
2008; Sherman, 2007).  Evidently, there is a need to change the current approach to cessation 
counseling in the VA health care system. Since VA primary care settings are likely to treat 
smokers who also present with alcohol, substance, or mental health disorders, and who may not 
enroll in specialty mental health treatment, the role and effectiveness of smoking cessation in VA 
primary care clinics for Veterans with mental health and substance use disorders is worth 
investigating.    
In sum, chronic mental illness and smoking both demonstrate associations with morbidity 
and mortality, and US military Veterans present in primary care with smoking prevalence and 
prevalence of some mental health disorders at relatively high rates.  Among Veterans, depression 
and PTSD are particulary common mental health concerns, and both confer risk for negative 
health outcomes. Emerging evidence in the smoking cessation treatment domain for individuals 
with mental illness suggests that integrated smoking cessation services provided by a mental 
health specialist lead to better cessation outcomes than the current standard of care, although 
further research in this domain is still desperately needed. Within the VA health care system, 
smoking cessation guideline implementation efforts have room for improvement, as studies show 
that only between 50% and 75% of smokers are advised to quit, and there is currently no 
systematic approach to offering counseling.  A better understanding of the characteristics of 
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depressed smokers and correlates of smoking in the VA primary care system may help identify 
issues important in the development of effective smoking cessation treatments for this 
population, which when considering cost-effectiveness and potential health benefits should be a 
high priority preventive service. 
Relevance of the Current Study 
Our sample of Veterans is unique in that it consists solely of depressed individuals, 
allowing us to examine differences between depressed smokers and nonsmokers so that we may 
help clarify important and distinctive factors that can influence smoking behavior in this 
population. We maintain that improved understanding of predictors and correlates of smoking 
status among depressed Veterans is crucial in the development of effective cessation 
interventions in this population. In addition, because all of the participants in our sample are 
depressed, we are provided with a unique opportunity to examine the impact of stigma on 
cigarette smoking between those who have the illness and experience greater levels of stigma 
and those who may not experience such high levels of stigma regarding their depression. 
Smoking status confers multiple health risks, which appear to exact particularly high 
costs for Veterans, many of whom already have multiple physical and mental health concerns. 
As noted above, smoking is linked to an increased risk of suicidal ideation and to a variety of 
negative physical and mental health outcomes, and the smoking behavior of depressed Veterans 
has received little attention in the research literature. In an effort to inform development of 
smoking cessation interventions for the population of depressed Veterans, the proposed study 
examined correlates and predictors of smoking status and successful smoking cessation among a 
sample of depressed Veterans in primary care. 
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 The specific aims of the current study were: (1) To determine smoking rates among 
depressed Veterans in primary care, (2) to identify physical and mental health correlates of 
smoking status (present, past, never) among depressed Veterans in primary care, and (3) to 
identify factors that predict smoking abstinence and cessation among depressed individuals over 
time. Ancillary aims included an examination of the relationship between smoking and suicidal 
ideation. Specifically, we wanted to investigate whether smoking status was predictive of higher 
risk for suicidal ideation and if this relationship still held after accounting for psychological 
comorbidities. A second ancillary aim was to examine the relationship between mental health 
stigma and smoking status.  
Anticipated Findings/Hypotheses: 
Consistent with previous studies, we predicted that compared to nonsmokers, smokers 
would evince higher depression severity, higher levels of alcohol consumption, worse PTSD 
symptomatology, more complex medical comorbidities, lower social support, increased risk for 
suicidal ideation, higher levels of mental health stigma, and increased care utilization for both 
emotional and physical problems. We also anticipated that few depressed primary care smokers 
would successfully quit smoking in the study window. 
Methods:   
The present project consists of a secondary data analysis of a longitudinal study, the 
Well-being Among Veterans Enhancement Study (WAVES), which evaluated a quality 
improvement depression intervention by means of a cluster randomized trial.  WAVES 
employed 10 VA primary practices in rural/semirural settings across 5 states.  Seven sites were 
randomized to receive an Evidence-Based Quality Improvement Collaborative Care Model for 
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depression (EBQI-CCM) and three were used as comparison sites.  Full details regarding 
WAVES can be found elsewhere (Chaney, Rubenstein, Liu, Yano, Bolkan, Lee, et al., 2011). 
Participants  
Researchers used VA electronic  
medical records from participating 
practices to identify possible participants 
based on whether they had a primary 
care appointment at one of the 
participating sites in the preceding 12 
months and a pending appointment 
within three months. Figure 1 describes 
the WAVES sampling strategy and the 
resulting sampling sizes for the baseline 
assessment. Potential participants were 
contacted by phone and screened for 
depression by trained interviewers from a 
contracted firm. Consenting participants 
were included in the study if they reported major depressive symptomatology on the Patient 
Health Questionnaire – 9 (PHQ-9: Kroenke, Spitzer, & Williams, 2001), a self-report measure of 
depressive symptomatology.  Exclusion criteria included conditions requiring urgent care (e.g., 
acute suicidality, psychosis) or lack of capacity to communicate over the telephone.  
As presented in the Figure, 14,794 patients were contacted by telephone and nearly 
11,000 patients were screened for depression with the PHQ-2, the first two items of the PHQ-9.  
Figure 1: Sampling Flow Chart 
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Just over 20% of these participants screened positive on the PHQ-2; ultimately, after full 
screening with the PHQ-9, 1,296 (59% of PHQ-2 screen positive) patients reported major 
depressive symptomatology and met WAVES inclusion criteria. Of these, 761 completed the full 
baseline measures. Follow-up assessments were conducted at 7- (n = 546, 72% of baseline) and 
18- (n = 370, 49% of baseline) months from baseline. Survey data were adjusted for enrollment 
probability (Chaney et al., 2011). Since the current proposal is unrelated to treatment, we will 
examine all WAVES participants simultaneously, collapsing the treatment and control site 
participants. IRB approval for the proposed analyses is granted and active at UCLA, and an 
exemption from full board review was granted by the University of Montana IRB.  
Measures 
The measures described below were collected by a contracted firm using Computer 
Assisted Telephone Interviews (CATI).  
Cigarette Smoking. Two questions assessed cigarette smoking at baseline.  Participants were 
asked whether they had smoked 100 cigarettes in their lifetimes and whether they still smoked 
cigarettes. The CDC (2002) defines an “ever smoker” using this 100 cigarette threshold. An 
additional question was asked to determine how long ago they quit smoking if they answered 
that they no longer smoked cigarettes. The follow-up smoking question at 7- and 18-month time 
points asked whether participants had smoked any cigarettes in the past 30 days (See Appendix). 
Smoking self-report has been found to be accurate in most smoking studies (Patrick, Cheadle, 
Thompson, & Diehr, 1994). We considered someone a ‘current smoker’ if he/she had smoked at 
least 100 cigarettes in his/her lifetime and answered ‘yes’ to whether or not he/she still smoked 
cigarettes. Participants who had smoked 100 cigarettes in their lifetimes, but answered ‘no’ to the 
question of whether or not they still smoked cigarettes were classified as ‘former smokers.’ 
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Finally, if participants answered ‘no’ to whether they had smoked 100 cigarettes in their lifetime 
and whether they still smoked, they were classified as ‘never smokers.’ We created a 
dichotomous category (smoker versus nonsmoker) by combining former and neversmoker and 
categorizing them as nonsmokers and current smokers were considered smokers. We used this 
dichotomous variable for our analysis because we considered it to be the most helpful and 
relevant for physicians assessing smoking status in primary care.  
Demographic characteristics. Study staff gathered demographic information regarding 
participant gender, age, ethnicity (dichotomized to White vs. non-White), level of education 
(dichotomized to high school or less vs. some college or more), relationship status (dichotomized 
to married/living as married vs. single), and current employment status (employed full or part-
time, unemployed, on disability, retired, or other).  
Depressive symptomatology. The PHQ-9 assessed depressive symptom severity. Participants 
indicated the frequency of Diagnostic and Statistical Manual of Psychiatric Disorders—4th 
edition (DSM-IV) (American Psychiatric Association [APA], 1994) major depressive episode 
symptoms over the past two weeks using a 4-point scale (0 = “not at all” – 3 = “every day/nearly 
every day”). Higher scores indicated worse symptomatology. The diagnostic validity of the 
PHQ-9 was established in studies involving 8 primary care and 7 obstetrical clinics, and PHQ 
scores > 10 had a sensitivity of 88% and a specificity of 88% for major depression (Kroenke, 
Spitzer, & Williams, 2001).  
Suicidality. A single question taken from the PHQ-9 was used to assess suicidality. Participants 
were asked to rate on a 4-point scale whether they had “thoughts that [they] would be better off 
dead or of hurting [themselves] in some way.” Higher scores represented more frequent thoughts 
about suicide.  Any response greater than “not at all” was coded positive for suicidal ideation.   
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Alcohol consumption. The Alcohol Use Disorders Identification Test consumption questions 
(AUDIT-C) (Bush, Kivlahan, McDonell, Fihn, & Bradley, 1998) assessed alcohol consumption. 
AUDIT-C responses were summed and higher scores indicated higher consumption.  The 
AUDIT-C predicts poor alcohol-related outcomes and scores greater than 8 are associated with 
morbidity and mortality (Bradley, Maynard, Kivlahan, et al., 2001). Because the research 
evidence indicates that low-level drinkers have lower rates of morbidity and mortality than 
nondrinkers, we categorized AUDIT-C scores into 8 levels (0, 1-3, 4-5, 6-7, 8-9, and >10), using 
scores of 1-3 as the reference category for our multivariate analysis (Dawson, 2006; Marmot, 
Shipley, Rose, & Thomas, 1981; Williams, Peytremann-Bridevaux, Fan, Bryson, Blough, 
Kivlahan, et al., 2010).  
Posttraumatic Stress Disorder. The primary care PTSD Screen (PC-PTSD) (Prins, Ouimette, 
Kimerling, Cameron, Hugelshofer, Shaw-Hegwer, et al., 2003) assessed PTSD. The PC-PTSD 
presents four questions that assess the presence or absence of four PTSD symptoms (i.e., 
reexperiencing, avoidance, hypervigilance, and emotional numbing related to past trauma). The 
measure produces scores ranging from 0 to 4, with scores greater than 3 predicting PTSD with 
acceptable sensitivity (0.78) and specificity (0.89) (Prins, Ouimette, Kimerling, Cameron, 
Hugelshofer, Shaw-Hegwer, et al., 2003).  
Anxiety and Panic. Participants were asked two ‘yes /no’ questions regarding the presence of 
general anxiety and panic attacks over the past 6 months. The questions asked whether they had 
felt “anxious much of the time and whether [they] experienced a panic attack when [they] 
suddenly felt intense fear and discomfort.” A follow-up question asked whether they had 
experienced a panic attack during the past month (CIDI, 1989).  
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General Health. A single item from the Health Status Questionnaire (Kazis et al., 1991) was 
used as an indicator of general health. Participants were asked to rate their overall perceived 
health on a five-point scale, ranging from “1 = excellent” to “5 = poor.” 
Medical comorbidities. The Seattle Index of Comorbidity (SIC) (Fan, Au, Heagerty, Deyo, 
McDonnell, & Fihn, 2002) was used to assess medical comorbidities by means of determining 
the presence/absence of seven chronic illness conditions, cigarette smoking status (see 
Appendix), and participant age. The SIC predicts hospitalization and mortality (Fan, Au, 
Heagerty, Deyo, McDonnell, & Fihn, 2002). 
Self-reported health care utilization. Participants reported the frequency of medical care utilized 
in the previous six months. Frequency of care for both physical and emotional problems was 
reported separately for the following treatment venues: outpatient, inpatient, and emergency 
department care. The derived variables were created by combining the total number of hospital 
admissions including those inside and outside the VA system for physical problems in the past 6 
months, and the total number of hospital admissions in and outside of the VA system for 
emotional problems. For outpatient care, we combined the total number of outpatient visits 
inside and outside of the VA system for a physical problem, and then the total number of 
outpatient visits inside and outside of the VA for an emotional problem.  
Perceptions about depression. Participants’ beliefs about depression and depression treatment 
were assessed using several items, with responses on a 5-point Likert scale (1 = ‘strongly agree’ 
to 5 = ‘strongly disagree’). To assess participants’ beliefs relevant to stigma, participants were 
asked whether they would conceal depression treatment from an employer and about their 
amenability to a depression diagnosis and depression treatment. Using a conceptual approach, we 
created a treatment amenability index by combining three items reflective of participants’ 
 
 
18 
‘perceptions about depression’. The three items (α = .72) included participants’ openness to 
depression treatment, their openness to a diagnosis of depression, and their beliefs that they were 
currently in need of depression treatment. Lower mean scores were considered to be indicative of 
higher amenability to treatment and diagnosis.  At 18-months, participants answered questions 
regarding their beliefs that depression treatment would result in devaluation by other people, the 
relative degree of comfort they felt related to depression vs. medical illness treatment, and their 
relative degree of comfort with primary vs. specialty mental health clinic depression care.  
Physical and mental health function. 11 items taken from the Short Form 36 v2 (SF-36) (Ware 
& Sherbourne, 1992) measure were used to assess physical and mental health function. The SF-
36 v2 is a widely use measure of quality of life and has been used in multiple studies with 
chronic illnesses (Asamo, Reid, Ali, Lipps, & Williams-Green, 2008). SF-11 and MHI-5 scaled 
scores indicating degree of limitations in function due to physical and mental illness were used. 
Higher scores were indicative of better physical and mental health function.  
Social support.  Eight items from the Medical Outcomes Study Social Support Scale 
(Sherbourne & Stewart, 1991) measured emotional and tangible social support. Higher mean 
scores indicated higher social support.  
Analysis 
Descriptive analyses were used to determine self-reported smoking rates in our sample. Smoking 
variables included having smoked at least 100 cigarettes in their lifetime, current smoking status, 
and how long ago participants quit smoking cigarettes. We also reported smoking status at 7- and 
18-month follow-up time periods.  Baseline differences between depressed current, former and 
never smokers were examined with respect to measures of theoretical and clinical interest. Initial 
comparisons examined bivariate differences for current, former and never smokers on a range of 
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demographic, psychosocial, health status and health utilization variables. A follow-up 
multivariate logistic regression analysis examined the odds of current smoking associated with 
the following measures: Demographic characteristics (gender, age, ethnicity, education, 
relationship status, living situation, and employment), depression severity, PTSD status, alcohol 
consumption, general and medical comorbidities, and social support. For this follow-up logistic 
regression analysis, we examined all of our predictor variables and looked for both conceptual 
and statistical reasons for including them in the model (e.g., if the literature indicated 
associations, and if the relationship was significant at the bivariate level at p < .10). 
Finally, descriptive analyses examined the proportion of depressed smokers at baseline who quit 
during the study window (i.e., over the course of 18 months).  
Results 
Participants 
Table 1 presents demographic characteristics for our sample. Participants had a mean age of 60 
(SD=12). 94% of our participants were male, 85.3% were Caucasian, 49.4% had less than a high 
school education, and 60.1% were married or living as married. 17.5% of participants were 
employed, and the mean depression score on the PHQ-9 was 17.5 (SD=4.2).  
Smoking Rates 
39.8% of our sample reported currently smoking cigarettes, and 81.6% reported lifetime smoking 
(>100 cigarettes). Three (.4%) participants reported that they had quit within the past 30 days, 13 
(1.7%) reported quitting from one month to one year prior to baseline, and 301 (39.6%) reported 
quitting more than one prior to baseline.  Regarding quit rates at 7 and 18-month follow-up 
assessments, only 7 (<1%) smokers had quit smoking at the 7 month follow-up, and 16 (2.1%) 
had quit at 18 months. 
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 Bivariate Analyses 
As shown in Table 1, bivariate analyses for physical and mental health correlates of smoking 
status indicated that relative to non-smokers, current smokers were more likely to be younger (p 
<. 001), less likely to be married (p <. 001), and more likely to be employed (p = .020). As 
hypothesized, in terms of physical and mental health problems, smokers exhibited higher 
depressive symptomatology (16.3 vs. 15.5, p = .02), reported more symptoms of PTSD on the 
PC-PTSD (2.1 vs. 1.5, p <.001), higher alcohol consumption (AUDIT-C) (2.8 vs. 1.5, p <.001), 
worse overall mental health status (MHI-5) (37.5 vs. 46, p <.001), more medical comorbidities 
(SIC) (7.6 vs. 6.7, p <.001), and less social support (3.4 vs. 3.8, p <.001). Anxiety and panic did 
not differ between groups, and contrary to our predictions, presence of suicidal ideation did not 
vary with smoking status.  
Regarding health utilization patterns, smokers and nonsmokers did not differ by number 
of hospitalizations for a physical problem over the past 6 months. Smokers and nonsmokers also 
reported similar proportions of outpatient visits for a physical or emotional problem and similar 
numbers of in-person visits with a mental health specialist.  However, compared to nonsmokers, 
smokers reported higher numbers of hospitalizations for an emotional problem (1.1 vs. 0.4, 
p=.05), and were more likely to have visited any mental health specialist, either in person or by 
telephone, over the 6 months prior to baseline (51.7% vs. 40.8%, p = .003). Smokers were also 
more likely to have missed a health care appointment over the past 6 months (41.3% vs. 31.4%, 
p = .005), and to have missed medication doses over the past 6 months (38.3% vs. 30.3%, p = 
.02). In addition, smokers were more amenable to depression treatment than nonsmokers (1.95 
vs. 2.3, p <.001). 
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Table	  1.	  Bivariate	  Comparisons:	  Demographic	  Characteristics	  and	  Physical	  and	  Mental	  Health	  
Correlates	  of	  Smoking	  Status	  
Characteristic	   Overall	  (n=761)	  
Smokers	  
(n=303)	  
Non-­‐Smokers	  
(n=458)	   P-­‐Values	  
Demographics	   	   	   	   	  
Mean	  Age	  (SD)	   60.3	  (12)	   55.4	  (9)	   63.6	  (13)	   <.001	  
Gender	  (%	  Male)	   94.0	   92.4	   95.0	   .15	  
Ethnicity	  (%	  White)	   85.3	   83.2	   86.8	   .17	  
Education	  (%	  <High	  School)	   49.4	   50.2	   48.9	   .73	  
Relationship	  Status	  (%	  Married/living	  
as	  married)	  
60.0	   50.2	   66.6	   <.001	  
Employment	  (%	  Working)	   17.5	   21.5	   14.9	   .02	  
Physical	  and	  Mental	  Health	   	   	   	   	  
Mean	  Depression	  Score	  (SD)	   15.8	  (4.3)	   16.3	  (4.4)	   15.6	  (4.2)	   .02	  
Mean	  PTSD	  Score	  (SD)	   1.8	  (1.7)	   2.1	  (1.6)	   1.5	  (1.7)	   <.001	  
Mean	  Alcohol	  Consumption	  Score	  
(AUDIT-­‐C)	  (SD)	  
2.0	  (3.1)	   2.8	  (3.8)	   1.5	  (2.4)	   <.001	  
Mean	  Mental	  Health	  Status	  Score	  
(SD)**	  
42.6	  (20.2)	   37.5	  (18.9)	   46.0	  (20.3)	   <.001	  
Overall	  Health	  (%	  fair/poor)	   80.4	   83.2	   78.6	   0.12	  
Mean	  Medical	  Comorbidities	  (SIC)	   7.1	  (3.3)	   7.6	  (2.8)	   6.7	  (3.6)	   <.001	  
Anxiety	  (%	  anxious)	   64.0	   67.7	   61.5	   .08	  
Panic	  (%	  yes)	   16.5	   19.3	   14.6	   .09	  
Suicidal	  Ideation	  (%	  yes)	   31.7	   33.6	   30.5	   0.37	  
Self-­‐Reported	  Healthcare	  Utilization	   	   	   	   	  
Any	  health	  care	  at	  VA—past	  6	  months	  
(%	  yes)	  
90.3	   91.4	   89.5	   .39	  
Visits	  to	  any	  mental	  health	  
specialist—past	  6	  months	  (%	  yes)	  
45.1	   51.7	   40.8	   .003	  
Primary	  care	  visit	  at	  VA	  –	  past	  6	  
months	  (%	  yes)	  
91.9	   93.2	   91.0	   .30	  
#	  of	  physical	  problem	  hospital	  
admissions	  
2.0	  (2.1)	   2.2	  (2.3)	   2.0	  (2.0)	   .67	  
#	  of	  emotional	  problem	  hospital	  
admissions	  
0.7	  (2.1)	   1.1	  (2.7)	   .4	  (1.8)	   .05	  
#	  of	  physical	  problem	  outpatient	  
visits	  
5.0	  (6.9)	   5.3	  (8)	   4.9	  (6)	   .54	  
#	  of	  emotional	  problem	  outpatient	  
visits	  
2.7	  (7.5)	   3.0	  (7.9)	   2.5	  (7.3)	   .50	  
#	  of	  in-­‐person	  visits	  with	  a	  mental	  
health	  specialist	  
6.4	  (9.7)	   5.8	  (9.7)	   6.9	  (9.8)	   .29	  
Missed	  an	  appointment—past	  6	   35.4	   41.4	   31.4	   .005	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months	  (%	  yes)	  
Missed	  doses	  of	  meds—past	  6	  
months	  (%yes)	  
33.5	   38.3	   30.3	   0.02	  
Psychosocial	  Variables	   	   	   	   	  
Total	  Social	  Support	  (SD)	   3.6	  (1.2)	   3.4	  (1.2)	   3.8	  (1.1)	   <.001	  
Stigma	  (Treatment	  Amenability)	  (SD)	   2.1	  (.9)	   2.0	  (.8)	   2.3	  (.9)	   <.001	  
*Data are adjusted for population weights and probability of enrollment. Significance tests 
included Χ2 analyses for categorical data and t tests for continuous data.  
**Mental health status refers to mental health function over the past month.  
 
Multivariate Analyses 
Table 2 shows results for multivariate analyses. After controlling for demographic 
characteristics, the most significant predictors of smoking status that emerged from the data were 
higher levels of alcohol consumption (scores of 1-3 on the AUDIT-C were used as the reference 
group), specifically AUDIT-C scores of 8-9, and scores of 10 or higher (p = .04 and p <.001 
respectively), and lower levels of social support (p = .01).  Logistic regression results indicate 
that depressed patients with scores between 8-9 on the AUDIT-C are almost three times more 
likely to smoke (OR=2.81, p = .04), than depressed patients who are low-level drinkers (scores 
of 1-3 on the AUDIT-C) and depressed patients with scores of 10 or higher on the AUDIT-C are 
almost 5 times more likely to smoke compared to depressed patients who drink less (OR=4.76, p 
<.001). Depressed patients with lower social support were more likely to smoke than depressed 
patients with higher levels of social support (OR=0.88, p = .01). 
To further examine and confirm the unique contributions of alcohol consumption and 
social support, we added an interaction term for the different levels of the AUDIT-C × social 
support means. The interaction was not significant, suggesting that the effects of social support 
on smoking were not dependent upon levels of alcohol consumption and that each of these 
variables appeared to evince independent relations with smoking status. In short, results of the 
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multivariate logistic regression suggested that, in our sample of older, depressed patients, the 
predominant factors that predicted smoking status were high levels of alcohol consumption that 
were indicative of significant misuse and low levels of social support. Although presence of 
PTSD and depression and high levels of stigma were associated with smoking status in the 
bivariate comparisons, these factors did not remain significant predictors of smoking in the 
controlled logistic analysis. Lastly, given that so few depressed Veterans had quit smoking at 7 
and 18 months, we did not have sufficient power to examine predictors of smoking cessation 
during the study window. Therefore, we did not conduct these follow-up analyses.   
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Table	  2.	  Summary	  of	  Logistic	  Regression	  Analyses	  for	  Variables	  Predicting	  Smoking	  Status	  (smoker	  
versus	  nonsmoker)	  among	  Veterans	  with	  Depression	  (n=	  761).	  
 95% Confidence Interval  
    
Predictor Variables 
Odds	  
Ratio	  
       
 
LL-UL P-­‐values	  
    
Mental Health     
    
 Depression Severity  1.0      0.97 – 1.06 .56 
 
 Alcohol Consumption *  
 
   
  AUDIT-C  Sum = 0  
 
1.1 0.73 – 1.74 .59 
  AUDIT-C  Sum = 4 -- 5 
 
1.1 0.56 – 2.22 .76 
  AUDIT-C  Sum = 6 -- 7 
 
1.5 0.69 – 3.05 .33 
  AUDIT-C  Sum = 8 -- 9 
 
2.8 1.03 – 7.63 .04 
  AUDIT-C  Sum > 10 
 
4.8 1.98 – 11.46 <.001 
 PTSD  1.1 0.75 – 1.59 .64 
    
    
Psychosocial Variables 
 
   
 Stigma  
 
1.1 
 
0.98 – 1.26 .15 
 Total Social Support 0.8 0.69 – 0.95 .01 
    
% Veterans with depression who smoke 39.8 
Note: Controls are age, ethnicity, education level, relationship status, and employment status (omitted 
from the table). LL-UL= Lower Limit-Upper Limit. Interaction term between AUDIT-C and Social 
Support was nonsignificant. Data are Weighted for Population and Probability of Enrollment.  
*Scores of 1-3 were used as the reference group. 
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Discussion 
Consistent with the existing mental health and smoking literature, study findings 
revealed high smoking rates in this population. Moreover, lifetime history of smoking in this 
sample was high, and the likelihood of quitting smoking over time was low. The low 
likelihood of quitting smoking over time in this population is extremely disconcerting, 
considering the increased risk for negative health outcomes associated with smoking, 
depression, and PTSD status. This population of depressed Veterans presenting in primary 
care is likely to continue to deteriorate in health as their smoking continues, their depression 
does not improve, problematic drinking continues, and their number of medical 
comorbidities increases while they remain socially isolated.  
Results from bivariate analyses indicated that compared to depressed nonsmokers, 
depressed smokers present to VA primary care settings with complex health circumstances 
in physical and mental health domains, including higher depressive symptomatology, higher 
likelihood of presence of comorbid PTSD, higher alcohol consumption, worse overall 
mental health status, more medical comorbidities, and lower levels of social support. A 
focused VA primary care intervention is imperative, as it appears that the usual care for 
smoking cessation is not very effective in this population. Although further research in this 
area is needed, integrated smoking cessation approaches in primary care, such as cessation 
counseling offered by a primary care provider, or the availability of on-call tobacco 
cessation staff, are showing promising results in the tobacco cessation literature.  
Our study also revealed higher numbers of hospital admissions for an emotional 
problem, higher amenability to depression treatment, and higher proportions of depressed 
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smokers reporting visits to any mental health specialist in the past six months. These 
findings present the potential gains of offering smoking cessation treatment for depressed 
smokers in VA mental health settings. Integrated tobacco treatment in mental health settings 
appear to be more effective than assessment of smoking followed by referral to separate 
smoking cessation clinics.  For example, McFall’s (2005) findings showing a 5-fold 
increased likelihood of cessation at 2, 4, 6, and 9 months in smokers with PTSD by 
providing integrated smoking cessation treatment demonstrate outstanding results in this 
domain. Moreover these results can have long-term effects. McFall’s (2010) second study—
the only other randomized tobacco treatment study among patients with PTSD—found 
integrated care to improve long-term (18-months) smoking abstinence rates by more than 
double of those referred to smoking cessation clinics.  
Studies in the tobacco treatment domain among smokers in outpatient depression 
treatment have also shown encouraging results. A stepped-care intervention tailored to 
depressed patients’ readiness to quit that included computerized motivational feedback, and 
an optional 6-session psychological counseling and pharmacological tobacco cessation 
treatment, resulted in significantly higher cessation rates than for the group receiving brief 
contact, a self-help guide to quit and referrals to smoking cessation clinics (Hall, Tsoh, 
Prochaska, Eisendrath, Redding, Rosen, et al., 2006). Similarly to depressed patients in 
these trials, depressed Veterans who smoke could also benefit by having integrated smoking 
cessation treatment in mental health settings.  
Controlling for covariates, multivariate analyses revealed that in our sample of older, 
depressed smokers in VA primary care, high levels of alcohol consumption and low levels 
of social support were the most significant predictors of smoking status. The levels of 
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alcohol consumption that were predictive of smoking in this study were indicative of 
problematic drinking (Bush, Kivlahan, McDonell, Fihn, & Bradley, 1998). Considering the 
synergistic role of smoking and alcohol misuse on increased risk for certain types of cancer 
and cardiovascular disease described earlier, addressing both alcohol consumption and 
smoking in primary care can be crucial in preventing worsening of current conditions and 
the development of new potentially life-threatening  diseases. 
Brief alcohol interventions have been shown to reduce alcohol use and health care 
related costs (Fleming, Mundt, French, Manwell, Stauffacher, & Barry, 2002), yet in a 
recent study examining VA medical records of outpatient soldiers serving in Operations 
Enduring Freedom and Iraqi Freedom with substance abuse from a cross-sectional national 
sample, findings indicated that only half of those patients with alcohol misuse had 
documented brief intervention or referral to alcohol treatment (Hawkins, Lapham, Kivlahan, 
& Bradley, 2010). These brief interventions (5-15 minutes) included advice to abstain from 
drinking or to drink within the recommended limits and some feedback regarding the health-
related risks of drinking. Management of alcohol misuse in primary care has been found to 
be cost-effective and to have a positive impact on patients’ health, yet research suggests that 
a minority of patients with alcohol misuse are currently being managed effectively 
(Calhoun, Elter, Jones, Kudler, & Straits-Troster, 2008; D’Amico, Paddock, Burman, & 
Kung, 2005; Rose, Miller, Nemeth, Jenkins, Nietert, Wessell, et al., 2008). 
Along similar lines, although integrated tobacco, alcohol, and substance abuse treatments 
has been shown to be the most effective method of treating concurrent addictions (U.S. 
Department of Health and Human Services, 2007), only 41% of outpatient substance abuse 
treatment programs offer smoking cessation counseling, with 17% providing cessation 
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medication (Friedmann, Jiang, & Ritchter, 2008). Some of the reasons for the low rates of 
smoking cessation treatment in substance abuse treatment settings include providers’ beliefs that 
smoking cessation would jeopardize substance abuse treatment (Goldsmith & Knapp, 1993; 
Gulliver, Kamholz, & Helstrom, 2006), and reliance on cigarettes by some providers to stabilize 
patients’ moods (Richter, 2006). Furthermore, only about 33% of alcohol abuse treatment 
providers in the United States reported that they agreed that alcohol abusers in treatment should 
be advised to quit smoking (Bobo, Slade, & Hoffman, 1995).  As stated earlier in this paper, 
targeting smoking in alcohol abuse treatment has not been found to negatively affect alcohol 
treatment outcomes, and has even been shown to result in improved success rates in alcohol 
abuse treatment. These misconceptions about integrated tobacco and alcohol and substance abuse 
treatment, and the undertreatment of tobacco dependence are alarmingly problematic, given the 
increased synergistic effects of smoking and alcohol abuse.  Implementation of smoking 
cessation services in these settings is strongly called for.  
One option to consider in addressing smoking in these settings is a harm-reduction 
approach. Intervention strategies recommending cessation counseling, but with an additional 
offering of an alternative smoking reduction program, can have the added advantage of attracting 
smokers who may not otherwise be interested in smoking cessation (Glasgow, Gaglio, France, 
Marcus, Riley, Levinson, et al; 2006). Some studies suggest that smokers who reduce their 
number of cigarettes smoked, can show improvements in biomarkers and respiratory symptoms 
(Gilpin & Pierce, 2003; Falba, Jofre-Bonet, Busch, Duchovny, & Sindelar, 2004; Hatsukami et 
al., 2002). In two studies conducted in the Kaiser Permanente Colorado healthcare system, 
among patients who were going to undergo outpatient surgery or outpatient surgery and GI 
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procedures, Glasgow et al., (2006) found a smoking reduction intervention offering both 
cessation and reduction options to be effective in attracting a large proportion of smokers to 
participate in smoking control efforts (12%-38% chose the cessation option, and an additional 
22-39% of smokers chose to participate in the smoking reduction program). Although further 
research is needed in this area, reduction approaches can be more appealing than cessation 
interventions to some smokers, attract a larger number of smokers, and reduce some of the health 
risks and symptoms associated with smoking.  
The findings related to social support are interesting and consistent with the literature 
showing associations between low social support and depression and to higher smoking cessation 
among smokers in smoking cessation treatment reporting more perceived social support. 
Smokers attempting to quit on their own show abstinence rates of about 5% or less (Hughes, 
Keely, & Naud, 2004).  Although our data are correlational and we cannot make causal 
inferences about social support and smoking, our findings suggests that our sample of depressed 
smokers may lack resources in terms of social support networks that could facilitate cessation 
services and lower depression rates. Smoking cessation groups, quit lines, individual cessation 
counseling, and electronic technologies, can be used to increase emotional, instrumental, and 
informational social support to individuals who are making quit attempts, and many smokers 
have been helped using these methods (Westmaas, Bontemps-Jones, & Bauer, 2010). Efforts 
aimed at increasing social support among depressed Veterans may prove beneficial in alleviating 
symptoms of depression and in raising their likelihood of quitting smoking.  
Finally, contrary to our expectations based on the literature linking smoking to completed 
suicide, smoking status in our sample was not associated with increased suicidal ideation. 
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However, it is possible that depression and comorbid medical and mental health conditions, both 
of which were high in our study play a mediating role in the increased risk for suicide that has 
been consistently associated with smoking in the literature. Further research in this area with 
more comprehensive controls may be needed in order to clarify the nature of the smoking and 
suicide association.  
The current study has several limitations. First, our sample consisted largely of 
older, male, Caucasian Veterans with depression, so these findings may apply to lesser or 
greater degrees in different populations. Second, because our sample consisted solely of 
depressed individuals, there was likely a restriction of range in depression scores that 
hamstrung our ability to predict smoking status by the severity of our participants’ 
depression. However, we were interested in finding differences between depressed smokers 
and nonsmokers rather than finding differences between depressed and nondepressed 
smokers, as other studies have examined.  The predictors of smoking status are therefore, 
predictors of smoking among depressed patients and cannot be generalized beyond this 
population.  
Third, our smoking measures were not the standard measures used in the smoking 
literature. We simply had information regarding smoking status and lacked the ability to 
examine nicotine dependence, number of cigarettes smoked per day, etc., and how these 
could vary based on depression, PTSD, etc.  However, for the purposes of primary care 
cessation guidelines, simply knowing about smoking status may be sufficient to take 
appropriate action for cessation efforts. Furthermore, primary care providers rely mostly on 
self-report and so are likely to take it at face value when addressing smoking issues with 
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patients. Lastly, our stigma measure consisted of one question regarding whether a 
participant would want to conceal their depression from their employer. Although this 
question is likely to get at some aspect of stigma, it probably does not encompass the full 
extent in which stigma can be experienced by a mental health patient.   
In spite of the limitations listed above, our study provides valuable information 
about depressed Veterans in primary care, a population that has not received much interest 
in the literature.  These patients present with complicated physical, mental health, and 
psychosocial problems that don’t appear likely to improve with standard care. Our research 
suggests a need for more comprehensive, integrated care in primary care, mental health 
settings, and substance abuse treatment settings in an effort to improve the current 
conditions of smokers presenting with depression, alcohol abuse, and mental and physical 
health comorbidities.  
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